Skip to main content
Figure 5 | BMC Immunology

Figure 5

From: Alteration of DSS-mediated immune cell redistribution in murine colitis by oral colostral immunoglobulin

Figure 5

Impact of prophylactic sIgA on cell distribution in lymph nodes and spleen at day 15. The indicated therapeutics (sIgA, IgG, and BC) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. Values are given as percent CD3+CD4+ (A), γδTCR+ (B), or CD11c+CD83+ (C) positive cells of 10,000 measured events and given as mean ± SD. n=6-8 (Untreated), n=6 (BC, sIgA), and n=5 (IgG) mice. *P<0.05 vs. untreated, Mann Whitney U-test.

Back to article page